bioRxivBioinformaticsPreprint
netCRS: Network-based comorbidity risk score for prediction of myocardial infarction using biobank-scaled PheWAS data
Yonghyun NamiD, Sang‐Hyuk JungiD, Anurag VermaiD, Vivek SriramiD, Hong‐Hee WoniD, Jae‐Seung YuniD, Dokyoon KimiD
Abstract
The polygenic risk score (PRS) can help to identify individuals genetic susceptibility for various diseases by combining patient genetic profiles and identified single-nucleotide polymorphisms (SNPs) from genome-wide association studies. Although multiple diseases will usually afflict patients at once or in succession, conventional PRSs fail to consider genetic relationships across multiple diseases. Even multi-trait PRSs, which take into account genetic effects for more than one disease at a time, fail to consider a sufficient number of phenotypes to accurately reflect the state of disease comorbidity in a patient, or are biased in terms of the traits that are selected. Thus, we developed novel network-based comorbidity risk scores to quantify associations among multiple phenotypes from phenome-wide association studies (PheWAS). We first constructed a disease-SNP heterogeneous multi-layered network (DS-Net), which consists of a disease network (disease-layer) and SNP network (SNP-layer). The disease-layer describes the population-level interactome from PheWAS data. The SNP-layer was constructed according to linkage disequilibrium. Both layers were attached to transform the information from a population-level interactome to individual-level inferences. Then, graph-based semi-supervised learning was applied to predict possible comorbidity scores on disease-layer for each subject. The SNP-layer serves as receiving individual genotyping data in the scoring process, and the disease-layer serves as the propagated output for an individuals multiple disease comorbidity scores. The possible comorbidity scores were combined by logistic regression, and it is denoted as netCRS. The DS-Net was constructed from UK Biobank PheWAS data, and the individual genetic profiles were collected from the Penn Medicine Biobank. As a proof-of-concept study, myocardial infarction (MI) was selected to compare netCRS with the PRS with pruning and thresholding (PRS-PT). The combined model (netCRS + PRS-PT + covariates) achieved an AUC improvement of 6.26% compared to the (PRS-PT + covariates) model. In terms of risk stratification, the combined model was able to capture the risk of MI up to approximately eight-fold higher than that of the low-risk group. The netCRS and PRS-PT complement each other in predicting high-risk groups of patients with MI. We expect that using these risk prediction models will allow for the development of prevention strategies and reduction of MI morbidity and mortality.
- organism: human
- assay: GWAS summary statistics
- research focus: benchmarking
- approach: statistical model
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Genetics in Context: Social Factors Modify Polygenic Risk Across Multiple Cardiometabolic Diseases
Micah R. Hysong, Sarah C Hsu, … Laura M. Raffield·medRxiv·Oct 29, 2026
- Polygenic risk vectors (PRV) improve genetic risk stratification for cardio-metabolic diseases
Ruowang Li, Xinyuan Zhang, … Jason H. Moore·medRxiv·Mar 2, 2022
- Comparison of polygenic risk scores for coronary artery disease highlights obstacles to overcome for clinical use
Holly Trochet, Justin Pelletier, … Julie Hussin·bioRxiv·Aug 9, 2020
- Association of polygenic risk scores for coronary artery disease with subsequent events amongst established cases
Laurence J Howe, Frank Dudbridge, … Riyaz S. Patel·Human Molecular GeneticsPeer-reviewed·Mar 24, 2020
- Large-scale evaluation of proteomic and polygenic risk scores reveals complementary contributions to incident disease prediction
Jakob Woerner, Thomas M. Westbrook, … Dokyoon Kim·medRxiv·Jul 10, 2025
- A systematic framework for assessing the clinical impact of polygenic risk scores
Scott Kulm, Andrew R. Marderstein, … Olivier Elemento·medRxiv·Apr 6, 2020